Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.50 |
| ▸ | ERN1 | O75460 | 5/20 | 0.47 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.44 |
| ▸ | RELA | Q04206 | 1/20 | 0.44 |
| ▸ | ALDH1A2 | O94788 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20339278 | 0.81 | RARA (0.49) | ALDH1A1ERN1KDM4ENPC1RAB9A | |
| SCHEMBL13680471 | 0.80 | TDP1 (0.50) | ALDH1A1ALDH1A3KDM4EHPGDMAPT | |
| SCHEMBL15709459 | 0.79 | ERN1 (0.47) | ALDH1A1ERN1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL4000335 | 0.79 | L3MBTL1 (0.51) | ALDH1A1ALDH1A3KDM4EHPGDMAPT | |
| SCHEMBL28928896 | 0.79 | ASIC3 (0.51) | ALDH1A1ALDH1A3KDM4EHPGDMAPT | |
| SCHEMBL17239418 | 0.79 | LMNA (0.44) | ALDH1A1ERN1KDM4EMAPTNPC1 | |
| SCHEMBL13680828 | 0.77 | ALDH1A1 (0.42) | ALDH1A1ERN1ALDH1A3KDM4EHPGD | |
| SCHEMBL2321964 | 0.76 | SMN1; SMN2 (0.41) | ALDH1A1ALDH1A3KDM4EHPGDMAPT | |
| SCHEMBL805864 | 0.76 | MAPT (0.64) | ALDH1A1ERN1HPGDMAPTNPC1 | |
| SCHEMBL20493592 | 0.76 | KMT2A (0.50) | ALDH1A1KDM4EHPGDMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2012500859-A | — | — | 2012-01-12 | — | — | JP | claimed |
| US-20110150803-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | FIRMENICH SA (CH) | 2011-06-23 | — | — | US | claimed |
| EP-2318100-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | Firmenich S.A. (CH) | 2011-05-11 | — | — | EP | claimed |
| WO-2010020954-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | FIRMENICH SA (CH) | 2010-02-25 | — | — | WO | claimed |
| US-12379315-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | ELITECHGROUP MDX LLC (US) | 2025-08-05 | — | — | US | disclosed |
| US-20220119424-A1 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | ELITechGroup MDX, LLC (US) | 2022-04-21 | — | — | US | disclosed |
| US-11242554-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | ELITECHGROUP, INC. (US) | 2022-02-08 | — | — | US | disclosed |
| US-20200299755-A1 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | ELITECHGROUP, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| US-10738346-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | ELITECHGROUP, INC. (US) | 2020-08-11 | — | — | US | disclosed |
| US-20200123146-A1 | HETEROCYCLIC INTEGRIN AGONISTS | GB006 INC (US) | 2020-04-23 | — | — | US | disclosed |
| US-20200123146-A1 | HETEROCYCLIC INTEGRIN AGONISTS | GB006 INC (US) | 2020-04-23 | — | — | US | disclosed |
| WO-2018162986-A2 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | ELITECHGROUP B.V. (NL) | 2018-09-13 | — | — | WO | disclosed |
| US-20180258471-A1 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | ELITECHGROUP B.V. (NL) | 2018-09-13 | — | — | US | disclosed |
| WO-2018126072-A1 | HETEROCYCLIC INTEGRIN AGONISTS | ADHAERE PHARMACEUTICALS, INC. (US) | 2018-07-05 | — | — | WO | disclosed |
| WO-2018126072-A1 | HETEROCYCLIC INTEGRIN AGONISTS | ADHAERE PHARMACEUTICALS, INC. (US) | 2018-07-05 | — | — | WO | disclosed |
| US-20110150803-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | FIRMENICH SA (CH) | 2011-06-23 | — | — | US | disclosed |
| EP-2318100-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | Firmenich S.A. (CH) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010020954-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | FIRMENICH SA (CH) | 2010-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110150803-A1 | EQUILIBRATED DYNAMIC MIXTURES CONTAINING STABILIZED HEMIACETALS FOR THE CONTROLLED RELEASE OF ACTIVE ALCOHOLS | ADH5, ADH1C, ADH1A | ALDH1A1 16/4885ERN1 4802/4885ALDH1A3 42/4885 |
| US-20220119424-A1 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | DNTT, NME2, DUT | ALDH1A1 640/4885ERN1 1805/4885ALDH1A3 690/4885 |
| US-20200299755-A1 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | DNTT, NME2, DUT | ALDH1A1 640/4885ERN1 1805/4885ALDH1A3 690/4885 |
| US-10738346-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | DNTT, NME2, DUT | ALDH1A1 640/4885ERN1 1805/4885ALDH1A3 690/4885 |
| US-11242554-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | DNTT, NME2, DUT | ALDH1A1 640/4885ERN1 1805/4885ALDH1A3 690/4885 |
| US-12379315-B2 | Nitrodiarylethenes as fluorescence quenchers for nucleic acid probes | DNTT, NME2, DUT | ALDH1A1 640/4885ERN1 1805/4885ALDH1A3 690/4885 |
| US-20200123146-A1 | HETEROCYCLIC INTEGRIN AGONISTS | ITGA1, ITGA4, ITGA2 | ALDH1A1 1447/4885ERN1 4169/4885ALDH1A3 3737/4885 |
| US-20180258471-A1 | NITRODIARYLETHENES AS FLUORESCENCE QUENCHERS FOR NUCLEIC ACID PROBES | DNTT, NME2, DUT | ALDH1A1 640/4885ERN1 1805/4885ALDH1A3 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.